Price
No data yet.
Social Signal Score
Revenue
$375.00M+17.04%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Bethany Owen
- Sector
- Utilities
- Industry
- Diversified Utilities
- Employees
- 1,595
- Beta
- 0.82
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 1.13
Financials
Revenue
$375.00M+17.0%Net Income
$27.10M-42.5%EBITDA
$114.60M+10.3%Free Cash Flow
$-174.20MEPS (diluted)
$0.47-48.0%Shares Outstanding (diluted)
58.20M+11.5%Cash & Debt
$78.70MReturn of Capital
$42.40MRevenue by Segment (annual)
$1.33BDividend per Share
$0.73Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $1.53B | $179.30M | $3.11 |
| 2023 | $1.88B | $247.10M | $4.31 |
| 2022 | $1.57B | $189.30M | $3.39 |
| 2021 | $1.42B | $169.20M | $3.23 |
| 2020 | $1.17B | $174.20M | $3.36 |
| 2019 | $1.24B | $185.60M | $3.60 |
| 2018 | $1.50B | $174.10M | $3.39 |
| 2017 | $1.42B | $172.20M | $3.39 |
| 2016 | $1.34B | $155.30M | $3.15 |
| 2015 | $1.49B | $141.10M | $2.92 |
| 2014 | $1.14B | $124.80M | $2.91 |
| 2013 | $1.02B | $104.70M | $2.64 |
| 2012 | $961.20M | $97.10M | $2.59 |
| 2011 | $928.20M | $93.80M | $2.66 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ALE's reported EPS growth of 1.2% a year over 13 years.
- EPS in 5 years
- $3.30
- Implied price
- $69.27
- Return from $67.90
- 0.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $34.44 — -49.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| -8.8% | -15.4% | -12.3% | -9.5% | -7.1% | -4.9% |
| -3.8% | -10.8% | -7.5% | -4.6% | -2.0% | 0.4% |
| 1.2% | -6.1% | -2.6% | 0.4% | 3.1% | 5.6% |
| 6.2% | -1.5% | 2.2% | 5.4% | 8.2% | 10.8% |
| 11.2% | 3.1% | 7.0% | 10.3% | 13.3% | 16.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsprnewswire.com·1d ago·Neutral
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline BioMarin to pay $275 million upfront, plus additional payments upon achievement of development and regulatory milestones Alesta to spin out all non-ALE1 assets to a new entity and Alesta employees to transfer to the spinout entity prior to close ALE1 has significant potential to help BioMarin expand into larger rare disease markets…
View source ↗
Earnings
Typical surprise -14.9% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Oct 31$0.46 vs $0.80miss
- Thu, Aug 7$0.61 vs $0.82miss
- Thu, May 8$1.01 vs $1.04miss
- Thu, Feb 13$0.87 vs $1.12miss
- Wed, Oct 30$0.78 vs $0.93miss
- Thu, Aug 1$0.82 vs $0.88miss
Estimates and results for ALE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ALE officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.